BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25391265)

  • 1. Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer.
    Nakagawa M; Inokuchi M; Takagi Y; Kato K; Sugita H; Otsuki S; Kojima K; Uetake H; Sugihara K
    Ann Surg Oncol; 2015 Jul; 22(7):2329-35. PubMed ID: 25391265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPX2 expression is associated with poor survival in gastric cancer.
    Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
    World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EphA1 in gastric carcinomas is associated with metastasis and survival.
    Wang J; Dong Y; Wang X; Ma H; Sheng Z; Li G; Lu G; Sugimura H; Zhou X
    Oncol Rep; 2010 Dec; 24(6):1577-84. PubMed ID: 21042754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
    Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of PAK4 expression in gastric cancer.
    Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
    J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of High EphA1-4 Expression Levels in Locally Advanced Gastric Cancer.
    Inokuchi M; Nakagawa M; Baogok N; Takagi Y; Tanioka T; Gokita K; Okuno K; Kojima K
    Anticancer Res; 2018 Mar; 38(3):1685-1693. PubMed ID: 29491103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
    Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
    Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
    Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
    World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
    Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
    Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.
    An JY; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Int J Cancer; 2010 Jun; 126(12):2904-13. PubMed ID: 19739122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
    Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
    World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
    Lin C; Zhang Z; Xu Y; Wang R; Chen S; Gao J; Wang D; Huang Q; Tu X; Wang L
    Am J Clin Pathol; 2016 Sep; 146(3):278-88. PubMed ID: 27543975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
    Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M
    Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
    Nagatsuma AK; Aizawa M; Kuwata T; Doi T; Ohtsu A; Fujii H; Ochiai A
    Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
    Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
    Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
    Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
    Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.